Match!

Optimal Surveillance Frequency After CRS/HIPEC for Appendiceal and Colorectal Neoplasms: A Multi-institutional Analysis of the US HIPEC Collaborative

Published on Jun 26, 2019in Annals of Surgical Oncology3.681
· DOI :10.1245/s10434-019-07526-1
Adriana C. Gamboa1
Estimated H-index: 1
(Emory University),
Mohammad Y. Zaidi4
Estimated H-index: 4
(Emory University)
+ 28 AuthorsShishir K. Maithel38
Estimated H-index: 38
(Emory University)
Abstract
Background No guidelines exist for surveillance following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) for appendiceal and colorectal cancer. The primary objective was to define the optimal surveillance frequency after CRS/HIPEC.
  • References (49)
  • Citations (1)
References49
Newest
#1Yael Feferman (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 2
#2D. Solomon (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 2
Last. Daniel M. Labow (ISMMS: Icahn School of Medicine at Mount Sinai)H-Index: 24
view all 8 authors...
Background This report describes patterns of disease recurrence after optimal cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) of colorectal (CRC) and appendiceal adenocarcinoma (AC) origin.
3 CitationsSource
#1Kim GovaertsH-Index: 1
#2K. ChandrakumaranH-Index: 18
Last. Brendan J Moran FrcsiH-Index: 54
view all 8 authors...
Abstract Aim Pseudomyxoma peritonei (PMP) is an uncommon malignancy, generally originating from a ruptured epithelial tumour of the appendix. Despite successful cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC), some patients recur. Currently there are no guidelines on the methods, frequency and intensity of follow-up. Methods Between 1994 and 2016, 1070 patients underwent surgery for a perforated epithelial tumour of the appendix, predominantly with PMP. Overall ...
2 CitationsSource
#1François QuenetH-Index: 25
#2Dominique EliasH-Index: 82
Last. Olivier GlehenH-Index: 46
view all 17 authors...
LBA3503Background: Promising results have been obtained during the last decade using cytoreductive surgery (CRS) plus HIPEC for selected patients with colorectal PC who are amenable to complete macroscopic resection. This is the first trial to evaluate the specific role of HIPEC, after CRS, for the treatment of PC of colorectal origin. Methods: Prodige 7 is a randomized phase III, multicenter trial. Patients with histologically proven and isolated PC, peritoneal cancer index (PCI) ≤25 were eligi...
66 CitationsSource
#1Peer Wille-Jørgensen (Bispebjerg Hospital)H-Index: 31
#2Ingvar SykH-Index: 21
Last. Henrik Toft S⊘rensen (Stanford University)H-Index: 100
view all 10 authors...
Importance Intensive follow-up of patients after curative surgery for colorectal cancer is common in clinical practice, but evidence of a survival benefit is limited. Objective To examine overall mortality, colorectal cancer–specific mortality, and colorectal cancer–specific recurrence rates among patients with stage II or III colorectal cancer who were randomized after curative surgery to 2 alternative schedules for follow-up testing with computed tomography and carcinoembryonic antigen. Design...
22 CitationsSource
#1Wijntje J. van Eden (NKI-AVL: Netherlands Cancer Institute)H-Index: 2
#2F. M. K. Elekonawo (Radboud University Nijmegen)H-Index: 1
Last. Arend G. J. Aalbers (NKI-AVL: Netherlands Cancer Institute)H-Index: 12
view all 7 authors...
Background Colorectal peritoneal carcinomatosis (PC) is preferably treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Peritoneal recurrence of disease after treatment can occur without distant metastases, with a variety of treatment options.
3 CitationsSource
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 47
#2Kimberly D. Miller Mph (ACS: American Cancer Society)H-Index: 2
Last. Ahmedin Jemal Dvm (ACS: American Cancer Society)H-Index: 4
view all 3 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the Nation...
3,124 CitationsSource
#1Walid L. ShaibH-Index: 12
#2Rita AssiH-Index: 4
Last. Bassel F. El-RayesH-Index: 29
view all 9 authors...
2 CitationsSource
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on cancer incidence, mortality, and survival. Incidence data, available through 2014, were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data, available through 2015, were collected by the Nation...
4,299 CitationsSource
#1Walid L. Shaib (Emory University)H-Index: 12
#2Rita Assi (AUB: American University of Beirut)H-Index: 4
Last. Bassel F. El-Rayes (Emory University)H-Index: 29
view all 9 authors...
13 CitationsSource
#1J.-B. DelhormeH-Index: 6
#2Charles HonoréH-Index: 23
Last. D. GoéréH-Index: 10
view all 9 authors...
Abstract Introduction Complete cytoreductive surgery (CCRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have dramatically changed the prognosis of patients with pseudomyxoma peritonei (PMP). However, recurrences can still occur and no consensus has been reached regarding their optimal treatments. This study aimed to analyze the patterns of recurrence after CCRS plus HIPEC for PMP and potential subsequent treatments of these lesions. Patients and methods Between 1992 and 2014, patients ...
9 CitationsSource
Cited By1
Newest
#1Michael K. Turgeon (Emory University)
#2Adriana C. Gamboa (Emory University)H-Index: 1
Last. Jula Veerapong (UCSD: University of California, San Diego)H-Index: 8
view all 22 authors...
BACKGROUND: Patient age is a significant factor in preoperative selection for major abdominal surgery. The association of age, tumor biology, and postoperative outcomes in patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) remains ill-defined. METHODS: Retrospective analysis was performed for patients who underwent a CCR0/1 CRS/HIPEC from the US HIPEC Collaborative Database (2000-2017). Age was categorized into /= 65 years. Primary outcome was p...
Source
#1M. Haroon A. Choudry (University of Pittsburgh)H-Index: 3
#2David L. Bartlett (University of Pittsburgh)H-Index: 49
Last. Kiran K. Turaga (U of C: University of Chicago)H-Index: 25
view all 4 authors...
Source